Vaccine Epidemic, now available in paperback from Skyhorse Publishing, turns the spotlight onto Gardasil, Merck's HPV vaccine. I saw a Tweet last week that referred to Gardasil as Merck's "Help Pay for Vioxx" Hail Mary pass. Vioxx was a painkiller that resulted in lawsuits that cost Merck almost $4 billion dollars. Most Americans are aware that when a drug harms or kills, the consumer has rights, including the right to sue for wrongful death or injury. Most are unaware that this is not so with vaccines, which are exempt from liability except in a tightly administered Federal court. Mark Blaxill wrote a 3 part series on Gardasil called, A License to Kill:
- A License to Kill? Part 1: Gardasil
- A License to Kill? Part 2: Gardasil
- A License to Kill? Part 3: Gardasil
Mark and Dan Olmsted also wrote a chapter for The Vaccine Epidemic that you can download.
The Vaccine Epidemic site has updated info on Gardasil, which has been controversial because of its connection to sexual activity (HPV, or genital warts, are sexually transmitted), its target patient of 11+ year old girls and the shift to offering it to boys after having marketed it as a cervical cancer vaccine for girls. The mere mention of Gardasil and injury may have cost Michelle Bachman her Presidential bid.
Gardasil, the controversial HPV vaccines given to teenage girls and boys. Learn about the money that's being made and the damage being done. See how other countries are banning the vaccine.
- A new report of infertility following HPV vaccination reported by the British Medical Journal
- France bans aluminum containing vaccines, including Gardasil
- Health professionals in Spain seek ban on Gardasil
- The Journal of the Royal Society of Medicine asks if cervical cancer data justifies HPV vaccination in India
- Class action lawsuit against Gardasil in Australia
- Ireland offers a Frequently Asked Questions guide for health practitioners that may oversimplify safety concerns
- Adverse events following HPV vaccination continue to pile up
Gardasil was licensed for use in 2006 for females aged 9 to 26 years. The CDC recommended it for sixth grade girls in 2007. In 2009, the FDA approved its use in males aged 9 to 26 years.
Twenty-four states introduced bills in 2007 to make Gardasil mandatory for school admission.
Gardasil is currently mandated for sixth graders in Virginia and the District of Columbia.
2007 $1.5 billion
2008 $1.4 billion
2009 $1.1 billion
2010 $998 million
2011 $1.2 billion
Second quarter 2012 sales are up 17% over the prior year.
Read more at The Vaccine Epidemic site.